The advertisement promotes SYMBRAVO, a prescription medication that combines meloxicam and rizatriptan to provide fast relief from acute migraine headaches.
Creative Information
| CID: | b838695a-4c4a-412d-abdd-8761a85173ab |
| CRID: | 97_7874535 |
| Domain: | healthgrades.com |
| Seat: | Verizon |
| Size: | 728x90 |
| Bid: | $0.20 |
| Timestamp: | 11/26/2025, 8:20:43 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/26/2025, 8:53:05 PM | 5.96s | |
| adomain_analysis | success | 11/26/2025, 8:52:58 PM | 2.92s | |
| adomain_capture | success | 11/26/2025, 8:52:55 PM | 0.26s | |
| ad_render | success | 11/26/2025, 8:52:59 PM | 10.50s | |
| brand_mapping | success | 11/26/2025, 8:20:44 PM | 0.10s | |
Analysis Results
Ad Format: banner
Brands: Healthgrades
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 2512.02 KB | ||||||||||||||||||||||
| Render Time: | 8.88 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Total Ad Size: | 2512.02 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Raw Ad Markup
<!-- DSP: Yahoo, TAGID: e1a5b5b6e3255540, CRID: 7874535, Buyer: 853 --><script type="text/javascript" src="https://pn.ybp.yahoo.com/ab/imp/FO5zJ1ssYE-Ecy0IvZ9tkW8iI5d5AbsYcPz5kDApCOSu7qvMXvBTIlzdOtlZHnTcFMI3mzzCDgleJibvCwnoKTu5-_9AdYom0L0WlHKMZkS4HnougST6o1e0hL0U2WghJNA7Q1L3bkWdkFQMAg7l8_ksRS71uUSokvTDxg_LEfj5ujaRzJW1deCKJ6ILvXLdR5M8gOSUy4sFGKjm7C1r0Ol4aSZPXJsTuE2kIuFmFQPYr4dPfwX6lM3yfMJQXqoAd8Z4FyvL-YPB_Pr3GopyoKEvpjjTtBNBQ_buRLP12WXiSt1z-k5pdKLUqv3IzatfBvU11J5YtCawTqygOxD5hYZvp3a9_1qaggG_FGabEiq2FPDtAO9HInClhY0Rb-6h_s8HEEI98h7A66iehCc1c75atCE-U4U2g_U1R_ZKOEDcp2sqDHJFaTy-MHJ0sAgYcymT3cth0fHH5RPV_y_Y8mn9cmGuuYpAsxtLI-pim_AEi452a5TfaGv9ahyEQX3qK3Y2OK5YOeY5o_S4vx2YFhitOSG1rQ9gB2NI9YZ9d_hSrcXwE_yO5hnyMSiCESemOmrbk04Nlr70H3B-99tVwf_MVCTuQ8gO4BaOW-6Vrlu6p-gzfmThTqHmD0WiBm_9YgyUTyF7v7OwnahGTV0Jnk51S7p18luVrDwX3QQuQHF9ak8TKOm70mvRprS4xQEqzZKsO_VTduDRlAMMmjKO8b0DstABfUIeXpW5kOHltlU-BM7cpnhI-jKR3o0mIMuLs4Qot9whK5Uo5tNltvLOd777Qkcwy2NSkr6K4-2IU2l-yG1zT5P2Ulp1fHob8aleaz_u-YiEyXeA2_9o1Kop8j7dN4M3XnQX7WGklPuP9Qfx8sRV8SJ88E53NVMG5106zvsbqjGw9VNjHFP77Z74jnIZpqj5iIKDOIczm3OpYCbKneKywshxgNY5Qlf9zwNo-pmePyWCYtiBY-Fhed_oJBLe4v-TZla-00lXPbmnZojo-eJgzT54uJvCHmhKcfBaHH_6H5a2DLYuxNWGcPGBsltq0_A2D7_CZmi-3XMAULcXxqiYHczTmBABCL0esLr5GtVWGb8G3i902t0qYgKZ-wpJLklGQ8XvvbnPrWrcC90qLI5yoHAKoIaVIt3Lf-k9vL7Je96GPPsJ16nKM6blBxAozSODt0LLIoF03O5NU2cg0Sn7CZ0HrMBbMeEbEZRItDC2QxbG2b9dnb8vYLpC1Ncors2P-WR-vWfslKgVBMnQ2zjALxc-QEtCmoLU0bI0vARqm8KNhf237SrwooWV-FEPCNypicj82bK_YRujqY70S5JS8HlLLJN_QJ6la3C_YnUepaso4m_QgG5sb0H9_mXH_Ckkh9bfNqqfhdLo8b9t5PjkdXje0tvEcXH1d1SGlzavWlrm_dOtS5hkssDRSEWxHwEkVF17noTyZ6Ssb3qlALIf3PD93CYqqosbiJqNS19uI3knBCs82MW4zaZ1_K9n0DcMiCJrhwG-Gl4wP2L2_qPmp7emNH0u65rybv_ZVvqaBlGl4xMiD8foH1IL-AR5uj1YwTQ-nTHI4mSrxE8Db0Aje4KsIv068KEcXWLGGSNjGS5aTe40ORE5Ae-UUmFbX9bZ0v4LxrqsZZCORGlscjALsGXh1ooupvJ1fyeZ8x6A230f-42svljyzGpg14uwbYf59mR0sZKcIvLV_2qBQEza15-Ydgn1sY-wOIxjB_czcXOmsaiCFEzYvvbStM72RAOIJF5N9l6ZhYerBE9iiSeX2rNPFBD6jut9J0pDuwe3UtzBCbfoBdvEVpfoz5cN75KvJqqNmRagLdqCz9vGynekD74yUlRi8MVAxmlIg2RXuV4fXinlixya_dO2YadD3HBf8QIg-Tb2fD3PJxFf7umWfIVk5dT-YFx79ikyq177Np0MqhiQ73mJG6J7GShAn5KM6Cwy4IGRYjecBrdW3q9U1lgIyzQLWbR9xwIIQndVI9U5gqmhxyG-utxW1G5lvgs2inO9/wp/0.20294502"></script>
Creatives


